1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsNIH Technology Accelerator Challenge is sponsored by NIBIB, NIH. Encourages development of non-invasive diagnostic technologies for sickle cell disease, with potential for additional support from the Gates Foundation.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
NIH Technology Accelerator Challenge (NTAC) | National Institute of Biomedical Imaging and Bioengineering NIH Technology Accelerator Challenge (NTAC) Division of Health Informatics Technologies (Informatics) Program Area: Digital Health - Mobile Health and Telehealth Prize Competition for Maternal Health NIBIB launched the NIH Technology Accelerator Challenge (NTAC) series of prize competitions to stimulate the design of new diagnostic technologies to transform public and global health and to accelerate the full development of those products for use in low-resource settings.
This iteration of NTAC awarded cash prizes for innovative diagnostic technologies to help improve maternal health by diagnosing conditions related to maternal morbidity and mortality. Pregnancy and childbirth complications are a major global health problem resulting in the deaths of more than 800 women and 7,000 newborns each day.
Contributing to the high rates of maternal morbidity and mortality in low-resource settings is the lack of low-cost diagnostics that operate at the point-of-care and are capable of detecting and differentiating common conditions during antenatal and intrapartum periods of pregnancy.
Therefore, the intended purpose of NTAC: Maternal Health was to spur and reward the development of low-cost, point-of-care molecular, cellular, and/or metabolic sensing and diagnostic technologies integrated with a digital platform to guide rapid clinical decision-making, improve patient outcomes, and ultimately prevent maternal morbidity and mortality. See links below to the 2022 prize winners and winner showcase webinar.
NTAC for Maternal Health 2022 Prize Winners Announced 2022 NTAC for Maternal Health Challenge Prize Winners NTAC for Maternal Health Winner Showcase Webinar Challenge winners presented their technologies at the VentureWell-hosted NTAC for Maternal Health Winner Showcase webinar. Watch a recording of the webinar.
NTAC for Maternal Health Announcement Announcement of Requirements and Registration for the NIH Technology Accelerator Challenge (NTAC) for Maternal Health can be found here. 2020 NTAC Challenge Winners See the list of 2020 winners of the NTAC Challenge.
According to the current listing, eligibility includes: Universities and research institutions developing diagnostic technologies. Confirm the full requirements in the official notice before applying.
The current listing shows up to $1,000,000 in prizes. Verify award ceilings, matching requirements, and allowable costs in the official notice.
NIH Technology Accelerator Challenge is funded by NIBIB, NIH. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
PA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read articlePA-27-034, PA-27-035 and PA-27-036 replace the institute-specific R25 announcements that research education programs have been built around for a decade. NCI, NIDA and NIGMS have already expired theirs early. Here is what the consolidation actually changes: an 8% indirect cost ceiling, a US-citizens-and-permanent-residents participant rule, a cooperative agreement variant that only exists on one of the three, and no clinical-trial-allowed companion anywhere.
Read article